NCT07119775Available不适用
Tideglusib: Expanded Access Use in Congenital Myotonic Dystrophy
相关药物
试验速览
- 阶段
- 不适用
- 状态
- Available
研究概览
简要总结
This treatment plan is limited to a single patient with Congenital Myotonic Dystrophy, who is ineligible or otherwise unable to participate in ongoing clinical trials.
研究设计
- 研究类型
- Expanded Access
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Efficacy and Tolerance of AVAPS Mode in Myotonic DystrophyMyopathyNCT01530841Centre d'Investigation Clinique et Technologique 80532
已完成
不适用
Observational Prolonged Trial in Myotonic Dystrophy Type 1Myotonic Dystrophy Type 1NCT02118779Radboud University Medical Center255
尚未招募
不适用
Presentation of Myotonic Dystrophy type 1 and 2 within a five-generation familymultisysteemaandoeningenPROMMSteinert's disease // Ricker's disease10083624NL-OMON36875niversitair Medisch Centrum Sint Radboud15
招募中
不适用
Australian Myelodysplastic Syndromes (MDS) Patient RegistryMyelodysplastic SyndromesCancer - Other cancer typesBlood - Haematological diseasesACTRN12620001012965Monash University300
终止
1 期
Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear MyopathiesCentronuclear MyopathyNCT04033159Dynacure14